Oxidative mechanisms of hemoglobin-based blood substitutes

被引:25
|
作者
Alayash, AI [1 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
关键词
hemoglobin; blood substitutes; oxidative stress;
D O I
10.1081/BIO-100108547
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Chemically or genetically altered cell-free hemoglobin (Hb) has been developed as an oxygen carrying therapeutic. Site-directed modifications are introduced and serve to stabilize the protein molecules in a tetrameric and/or a polymeric functional form. Direct cytotoxic effects associated with cell-free Hb have been ascribed to redox reactions (involving either I or 2 electron steps) between the heme group and peroxides. These interactions are the basis of the pseudoperoxidase activity of Hb and can be cytotoxic when reactive species are formed at relatively high concentrations during inflammation and typically lead to cell death. Peroxides relevant to biological systems include hydrogen peroxide (H2O2), lipid hydroperoxides (LOOH), and peroxynitrite (ONOO-). Reactions between Hb and peroxides form the ferryl oxidation state of the protein, analogous to compounds I and II formed in the catalytic cycle of many peroxidase enzymes. This higher oxidation state of the protein is a potent oxidant capable of promoting oxidative damage to most classes of biological molecules. Further complications are thought to arise through the disruption of key signaling pathways resulting from alteration of or destruction of important physiological mediators.
引用
收藏
页码:415 / 425
页数:11
相关论文
共 50 条
  • [31] Effects of hemoglobin-based blood substitutes on vasoactivity of rat aortic rings
    de Figueiredo, LFP
    Nelson, SH
    Mathru, T
    Silva, MRE
    Kramer, GC
    ARTIFICIAL ORGANS, 2001, 25 (11) : 928 - 933
  • [32] Hemoglobin-based blood substitutes and risk of myocardial infarction and death - Reply
    Fergusson, Dean
    McIntyre, Lauralyn
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (11): : 1299 - 1299
  • [33] The status of hemoglobin-based red cell substitutes
    Rabinovici, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (09): : 691 - 697
  • [34] The prospect of hemoglobin-based blood substitutes: Still a long stony road to go
    Bone, HG
    Westphal, M
    CRITICAL CARE MEDICINE, 2005, 33 (03) : 694 - 695
  • [35] Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes
    Kavdia, M
    Tsoukias, NM
    Popel, AS
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (06): : H2245 - H2253
  • [36] GENETIC-ENGINEERING OF MYOGLOBIN AS A SIMPLE PROTOTYPE FOR HEMOGLOBIN-BASED BLOOD SUBSTITUTES
    OLSON, JS
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 1994, 22 (03): : 429 - 441
  • [37] Low affinity PEGylated hemoglobin from Trematomus bernacchii, a model for hemoglobin-based blood substitutes
    Coppola, Daniela
    Bruno, Stefano
    Ronda, Luca
    Viappiani, Cristiano
    Abbruzzetti, Stefania
    di Prisco, Guido
    Verde, Cinzia
    Mozzarelli, Andrea
    BMC BIOCHEMISTRY, 2011, 12
  • [38] Effect of hemoglobin-based blood substitutes on nitric oxide transport: Mathematical models
    Popel, AS
    Kavdia, M
    Tsoukias, NM
    ARTIFICIAL OXYGEN CARRIER: ITS FRONT LINE, 2005, 12 : 176 - 185
  • [39] Protein engineering strategies for designing more stable hemoglobin-based blood substitutes
    ARTIF. CELLS BLOOD SUBSTITUTES IMMOBILIZATION BIOTECHNOL., 1-2 (227-241):
  • [40] NONENCAPSULATED HEMOGLOBIN-BASED RED-BLOOD-CELL SUBSTITUTES - AN UPDATED VIEW
    SHEFFIELD, CL
    DELOACH, JR
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1991, 14 (03) : 249 - 255